Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Lawitz, Eric, Poordad, Fred F, Pang, Phillip S, Hyland, Robert H, Ding, Xiao, Mo, Hongmei, Symonds, William T, McHutchison, John G, Membreno, Fernando EVolume:
383
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(13)62121-2
Date:
February, 2014
File:
PDF, 400 KB
english, 2014